Top 20 of Musculoskeletal Diseases

Article title # Publications/# Citations

Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)

1996: PCAmadio; CBombardier; PLHudak;

224

Burden of major musculoskeletal conditions.

2003: BPfleger; ADWoolf;

207

Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.

2000: SJLinton; JWVlaeyen;

181

The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

2005: JSim; CCWright;

163

Pathophysiology and therapeutic potential of purinergic signaling.

2006: GBurnstock;

115

Overweight, obesity, and health risk.

2000: National Task Force on the Prevention and Treatment of Obesity;

103

Plaque production by the polyoma virus.

1959: RDulbecco; GFreeman;

101

The fear-avoidance model of musculoskeletal pain: current state of scientific evidence.

2006: KBoersma; GCrombez; MEGoossens; MLeeuw; SJLinton; JWVlaeyen;

94

Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study.

2003: HSPicavet; JSSchouten;

93

Evidence for prescribing exercise as therapy in chronic disease.

2006: BKPedersen; BSaltin;

88

Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity.

2001 Apr-Jun: DEBeaton; CBombardier; AHFossel; JNKatz; VTarasuk; JGWright;

88

Role of transforming growth factor-beta superfamily signaling pathways in human disease.

2008: GCBlobe; KJGordon;

85

Psychosocial factors at work and musculoskeletal disease.

1993: PMBongers; CRde Winter; VHHildebrandt; MAKompier;

83

Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation.

1998: TAllison; TBrammah; HBusby; MRoxby; ASimmons; DSymmons; MUrwin; GWilliams;

73

Rituximab for steroid-refractory chronic graft-versus-host disease.

2006: EAlyea; JHAntin; DBienfang; CCutler; VHo; HTKim; LBKlickstein; SJLee; ... JLevin; RMacdonell; DMiklos; KMiller; MPasek; CReynolds; JRitz; RSoiffer; NTreister; SBWoo;

72

Tissue engineering: orthopedic applications.

1999: AMAmbrósio; MDBorden; JACooper; CTLaurencin;

72

Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003.

2004: AEBauman;

72

Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.

2004: MACaudill-Slosberg; LMSchwartz; SWoloshin;

71

The consequences of childhood overweight and obesity.

2006: SRDaniels;

69

The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states.

1997: SRonca-Testoni; RZucchi;

69